Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9266809rdf:typepubmed:Citationlld:pubmed
pubmed-article:9266809lifeskim:mentionsumls-concept:C0032343lld:lifeskim
pubmed-article:9266809lifeskim:mentionsumls-concept:C0042523lld:lifeskim
pubmed-article:9266809lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9266809lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:9266809pubmed:issue2lld:pubmed
pubmed-article:9266809pubmed:dateCreated1997-9-12lld:pubmed
pubmed-article:9266809pubmed:abstractTextVerapamil poisoning is known to produce hyperglycemia and metabolic acidosis in humans. The purpose of this study was to elucidate mechanisms of verapamil-induced hyperglycemia in awake dogs. Mongrel canines were chronically instrumented to permit studies in the conscious state. In six healthy dogs, steady-state glucose infusion requirement after 1 hr of insulin infusion at 1000 mU/min was 19 +/- 1 mg/kg/min. In six separate dogs, verapamil toxicity was induced via verapamil infusion in the portal vein; during verapamil toxicity, the glucose infusion requirement with an insulin infusion rate of 1000 mU/min was significantly decreased (3 +/- 1 mg/kg/min; p < 0.05, unpaired t test). Eleven other verapamil-toxic dogs were also treated with either saline (n = 6, 3.0 ml/kg/hr) or glucagon (n = 5, 10 microg/kg/min). Insulin concentrations were not changed vs basal concentrations in either group. Catecholamine concentrations increased at least 15-fold in all groups (from 458 +/- 169 to 6973 +/- 480 pg/L in the saline-treated group). Glucose concentrations increased in saline-treated animals from 3.7 +/- 0.3 to 11.2 +/- 1.0 micromol/L, and with glucagon treatment, increased from 3.3 +/- 0.3 to 16.1 +/- 1.6 micromol/L (p < 0.05 vs saline, ANOVA). Verapamil poisoning appears to produce hyperglycemia by inducing systemic insulin resistance, blocking insulin release, together with an intact stress hormone response and glucogenic capacity.lld:pubmed
pubmed-article:9266809pubmed:languageenglld:pubmed
pubmed-article:9266809pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9266809pubmed:citationSubsetIMlld:pubmed
pubmed-article:9266809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9266809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9266809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9266809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9266809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9266809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9266809pubmed:statusMEDLINElld:pubmed
pubmed-article:9266809pubmed:monthAuglld:pubmed
pubmed-article:9266809pubmed:issn0041-008Xlld:pubmed
pubmed-article:9266809pubmed:authorpubmed-author:WattsJ AJAlld:pubmed
pubmed-article:9266809pubmed:authorpubmed-author:RaymondR MRMlld:pubmed
pubmed-article:9266809pubmed:authorpubmed-author:KlineJ AJAlld:pubmed
pubmed-article:9266809pubmed:authorpubmed-author:SchroederJ...lld:pubmed
pubmed-article:9266809pubmed:issnTypePrintlld:pubmed
pubmed-article:9266809pubmed:volume145lld:pubmed
pubmed-article:9266809pubmed:ownerNLMlld:pubmed
pubmed-article:9266809pubmed:authorsCompleteYlld:pubmed
pubmed-article:9266809pubmed:pagination357-62lld:pubmed
pubmed-article:9266809pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:meshHeadingpubmed-meshheading:9266809-...lld:pubmed
pubmed-article:9266809pubmed:year1997lld:pubmed
pubmed-article:9266809pubmed:articleTitleThe diabetogenic effects of acute verapamil poisoning.lld:pubmed
pubmed-article:9266809pubmed:affiliationDepartment of Emergency Medicine, Carolinas Medical Center, Charlotte, North Carolina 28232, USA.lld:pubmed
pubmed-article:9266809pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9266809lld:pubmed